human breast cancer specimen; adjacent benign tissues; tumor xenografts; tumor tissues; muscle tissues
MCF-10A; HaCaT; 293T; Jurkat; MCF10A; MCF-7; MDA-MB-468; MDA-MB-231; HTB126; SK-BR-3; H460; LnCap; Du145; PC3; SNU449; HepG2; CI3K; A549; HeLa
cell line-derived xenograft
proliferation (promotes); migration (promotes); invasion (promotes); metastasis (promotes); other pathway/process (promotes)
Microarray; RT-qPCR; Northern Blot; RNase R Treatment; Sanger Sequencing; Transfection; Clinical Sample Validation; RNA Pull-Down; RIP (RNA Immunoprecipitation); Co-IP; FISH / smFISH; Nuclear-Cytoplasmic Fractionation; Transwell Assay; Wound Healing Assay; In Vivo Animal Model; H&E Staining; Western Blot; Bioinformatics Analysis
circSKA3 is highly expressed in human breast cancer patient samples and positively correlated with disease staging.
circSKA3 is up-regulated in human breast cancer cells and tissues and is positively correlated with disease stage. It promotes breast cancer migration, invasion, proliferation, tumor progression, and invadopodium formation by binding and bridging Itgb1/integrin beta1 and Tks5 at the membrane/invadopodia. In xenograft models, circSKA3 overexpression increases tumor growth and invasion, whereas circSKA3 silencing reduces invadopodia and improves mouse survival.
0.8395
The Circular RNA circSKA3 Binds Integrin beta1 to Induce Invadopodium Formation Enhancing Breast Cancer Invasion.
combined biological and clinical study